These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10686424)

  • 1. Deletion of cysteine 369 in lysyl hydroxylase 1 eliminates enzyme activity and causes Ehlers-Danlos syndrome type VI.
    Yeowell HN; Allen JD; Walker LC; Overstreet MA; Murad S; Thai SF
    Matrix Biol; 2000 Feb; 19(1):37-46. PubMed ID: 10686424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel mutation in the lysyl hydroxylase 1 gene causes decreased lysyl hydroxylase activity in an Ehlers-Danlos VIA patient.
    Walker LC; Overstreet MA; Siddiqui A; De Paepe A; Ceylaner G; Malfait F; Symoens S; Atsawasuwan P; Yamauchi M; Ceylaner S; Bank RA; Yeowell HN
    J Invest Dermatol; 2005 May; 124(5):914-8. PubMed ID: 15854030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A compound heterozygote patient with Ehlers-Danlos syndrome type VI has a deletion in one allele and a splicing defect in the other allele of the lysyl hydroxylase gene.
    Pousi B; Hautala T; Hyland JC; Schröter J; Eckes B; Kivirikko KI; Myllylä R
    Hum Mutat; 1998; 11(1):55-61. PubMed ID: 9450904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A null-mutated lysyl hydroxylase gene in a compound heterozygote British patient with Ehlers-Danlos syndrome type VI.
    Heikkinen J; Pousi B; Pope M; Myllylä R
    Hum Mutat; 1999 Oct; 14(4):351. PubMed ID: 10502784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A patient with Ehlers-Danlos syndrome type VI is a compound heterozygote for mutations in the lysyl hydroxylase gene.
    Ha VT; Marshall MK; Elsas LJ; Pinnell SR; Yeowell HN
    J Clin Invest; 1994 Apr; 93(4):1716-21. PubMed ID: 8163671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the lysyl hydroxylase 1 gene that result in enzyme deficiency and the clinical phenotype of Ehlers-Danlos syndrome type VI.
    Yeowell HN; Walker LC
    Mol Genet Metab; 2000; 71(1-2):212-24. PubMed ID: 11001813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ehlers-Danlos syndrome type VI results from a nonsense mutation and a splice site-mediated exon-skipping mutation in the lysyl hydroxylase gene.
    Yeowell HN; Walker LC
    Proc Assoc Am Physicians; 1997 Jul; 109(4):383-96. PubMed ID: 9220536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A patient with Ehlers-Danlos syndrome type VI is homozygous for a premature termination codon in exon 14 of the lysyl hydroxylase 1 gene.
    Walker LC; Marini JC; Grange DK; Filie J; Yeowell HN
    Mol Genet Metab; 1999 May; 67(1):74-82. PubMed ID: 10329027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A splice-site mutation that induces exon skipping and reduction in lysyl hydroxylase mRNA levels but does not create a nonsense codon in Ehlers-Danlos syndrome type VI.
    Pajunen L; Suokas M; Hautala T; Kellokumpu S; Tebbe B; Kivirikko KI; Myllylä R
    DNA Cell Biol; 1998 Feb; 17(2):117-23. PubMed ID: 9502428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational analysis of the lysyl hydroxylase 1 gene (PLOD) in six unrelated patients with Ehlers-Danlos syndrome type VI: prenatal exclusion of this disorder in one family.
    Yeowell HN; Walker LC; Farmer B; Heikkinen J; Myllyla R
    Hum Mutat; 2000 Jul; 16(1):90. PubMed ID: 10874315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenoviral gene transfer restores lysyl hydroxylase activity in type VI Ehlers-Danlos syndrome.
    Rauma T; Kumpumäki S; Anderson R; Davidson BL; Ruotsalainen H; Myllylä R; Hautala T
    J Invest Dermatol; 2001 Apr; 116(4):602-5. PubMed ID: 11286629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mRNA and the activity of lysyl hydroxylase are up-regulated by the administration of ascorbate and hydralazine to human skin fibroblasts from a patient with Ehlers-Danlos syndrome type VI.
    Yeowell HN; Walker LC; Marshall MK; Murad S; Pinnell SR
    Arch Biochem Biophys; 1995 Aug; 321(2):510-6. PubMed ID: 7646078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal exclusion of Ehlers-Danlos syndrome type VI by mutational analysis.
    Yeowell HN; Walker LC
    Proc Assoc Am Physicians; 1999; 111(1):57-62. PubMed ID: 9893157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and expression of the human lysyl hydroxylase gene (PLOD): introns 9 and 16 contain Alu sequences at the sites of recombination in Ehlers-Danlos syndrome type VI patients.
    Heikkinen J; Hautala T; Kivirikko KI; Myllylä R
    Genomics; 1994 Dec; 24(3):464-71. PubMed ID: 7713497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ehlers-Danlos syndrome type VI: lysyl hydroxylase deficiency due to a novel point mutation (W612C).
    Brinckmann J; Açil Y; Feshchenko S; Katzer E; Brenner R; Kulozik A; Kügler S
    Arch Dermatol Res; 1998 Apr; 290(4):181-6. PubMed ID: 9617436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A common duplication in the lysyl hydroxylase gene of patients with Ehlers Danlos syndrome type VI results in preferential stimulation of lysyl hydroxylase activity and mRNA by hydralazine.
    Yeowell HN; Walker LC; Murad S; Pinnell SR
    Arch Biochem Biophys; 1997 Nov; 347(1):126-31. PubMed ID: 9344473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duplication of seven exons in the lysyl hydroxylase gene is associated with longer forms of a repetitive sequence within the gene and is a common cause for the type VI variant of Ehlers-Danlos syndrome.
    Heikkinen J; Toppinen T; Yeowell H; Krieg T; Steinmann B; Kivirikko KI; Myllylä R
    Am J Hum Genet; 1997 Jan; 60(1):48-56. PubMed ID: 8981946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of lysyl hydroxylase 2 (LH2) in skin fibroblasts from three Ehlers-Danlos patients does not result from mutations in either the coding or proximal promoter region of the LH2 gene.
    Walker LC; Teebi AS; Marini JC; De Paepe A; Malfait F; Atsawasuwan P; Yamauchi M; Yeowell HN
    Mol Genet Metab; 2004 Dec; 83(4):312-21. PubMed ID: 15589118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nonsense codon of exon 14 reduces lysyl hydroxylase mRNA and leads to aberrant RNA splicing in a patient with Ehlers-Danlos syndrome type VI.
    Pousi B; Heikkinen J; Schröter J; Pope M; Myllylä R
    Mutat Res; 2000 Feb; 432(1-2):33-7. PubMed ID: 10729709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A homozygous stop codon in the lysyl hydroxylase gene in two siblings with Ehlers-Danlos syndrome type VI.
    Hyland J; Ala-Kokko L; Royce P; Steinmann B; Kivirikko KI; Myllylä R
    Nat Genet; 1992 Nov; 2(3):228-31. PubMed ID: 1345174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.